Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FATE | NKTX | SPRO | ||
| Company | Fate Therapeutics | Nkarta Inc | Spero Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.1200 | 1.8700 | 2.36 | ||
| High | 1.1650 | 1.9000 | 2.36 | ||
| Low | 1.0900 | 1.8100 | 2.30 | ||
| Latest | 1.1500 | 1.8800 | 2.32 | ||
| Change | +0.0400 | +0.0100 | -0.03 | ||
| % Change | +3.60% | +0.53% | -1.28% | ||
| Volume | 1,407,600 | 719,000 | 287,700 | ||
| 20-Day Average Volume | 1,219,535 | 651,575 | 343,190 | ||
| Previous Close | 1.1100 | 1.8700 | 2.35 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.0591 | 1.8230 | 2.33 | ||
| 20-Day Raw Stochastic | 93.02% | 78.26% | 35.90% | ||
| 20-Day Relative Strength | 51.11 | 47.29 | 50.12 | ||
| Weighted Alpha | -50.44 | -24.50 | -19.28 | ||
| Today's Opinion | 8% Sell | 40% Sell | 40% Buy | ||
| Previous Opinion | 24% Sell | 40% Sell | 88% Buy | ||
| Last Month's Opinion | 8% Buy | 8% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.48% since 12/05/25 | +4.44% since 12/05/25 | +2.65% since 12/05/25 | ||
| Low | 1.0300 on 12/08/25 | 1.7800 on 12/08/25 | 2.26 on 12/09/25 | ||
| High | 1.1650 on 12/12/25 | 1.9000 on 12/12/25 | 2.39 on 12/10/25 | ||
| 1-Month | |||||
| %Chg | +10.58% since 11/12/25 | -4.08% since 11/12/25 | -12.78% since 11/12/25 | ||
| Low | 0.9500 on 11/14/25 | 1.7000 on 11/21/25 | 2.18 on 12/03/25 | ||
| High | 1.1650 on 12/12/25 | 1.9850 on 11/13/25 | 2.72 on 11/13/25 | ||
| 3-Month | |||||
| %Chg | +19.41% since 09/12/25 | -4.57% since 09/12/25 | +22.11% since 09/12/25 | ||
| Low | 0.9401 on 09/15/25 | 1.7000 on 11/21/25 | 1.84 on 09/30/25 | ||
| High | 1.9399 on 10/27/25 | 2.7400 on 10/16/25 | 2.75 on 11/12/25 | ||
| 6-Month | |||||
| %Chg | -17.86% since 06/12/25 | -1.57% since 06/12/25 | -19.72% since 06/12/25 | ||
| Low | 0.9100 on 08/11/25 | 1.6300 on 07/01/25 | 1.80 on 08/20/25 | ||
| High | 1.9399 on 10/27/25 | 2.7400 on 10/16/25 | 3.22 on 07/09/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 132,655 | 133,536 | 130,706 | ||
| Shares Outstanding, K | 115,352 | 71,030 | 56,339 | ||
| Annual Sales | 13,630,000 | 0 | 47,980,000 | ||
| Annual Net Income | -186,260,000 | -108,790,000 | -68,570,000 | ||
| Last Quarter Sales | 1,740,000 | 0 | 5,440,000 | ||
| Last Quarter Net Income | -32,250,000 | -21,720,000 | -7,380,000 | ||
| 60-Month Beta | 2.34 | 0.80 | 1.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 11/13/25 | -0.29 on 11/10/25 | -0.13 on 11/13/25 | ||
| Latest Earnings Date | 03/04/26 | 03/25/26 | 03/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 09/16/15 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||